en
Scientific article
Open access
French

Furosémide intraveineux dans l’insuffisance cardiaque aiguë : administration continue ou intermittente ?

Published inRevue médicale suisse, vol. 18, no. 801, p. 2004-2011
Publication date2022-10-26
Abstract

Loop diuretics are strongly recommended by current guidelines for the treatment of acute heart failure. Intravenous furosemide can be administered either as a continuous infusion or as an intermittent bolus. The choice between these two routes is not always obvious in clinical practice. The understanding of their different mechanisms of action, as well as the notion of diuretic resistance, can help identify patients who may benefit from either of these two routes. This article aims at discussing these aspects and their pathophysiology, as well as summarizing the current body of evidence from randomized trials comparing continuous vs. intermittent administration of furosemide in acute heart failure.

engfre
Keywords
  • Humans
  • Furosemide / therapeutic use
  • Injections, Intravenous
  • Infusions, Intravenous
  • Sodium Potassium Chloride Symporter Inhibitors / therapeutic use
  • Diuretics / therapeutic use
  • Heart Failure / drug therapy
Citation (ISO format)
DIAS, Joana et al. Furosémide intraveineux dans l’insuffisance cardiaque aiguë : administration continue ou intermittente ? In: Revue médicale suisse, 2022, vol. 18, n° 801, p. 2004–2011. doi: 10.53738/REVMED.2022.18.801.2004
Main files (1)
Article (Published version)
accessLevelPublic
Identifiers
ISSN of the journal1660-9379
21views
1downloads

Technical informations

Creation10/19/2023 2:13:53 PM
First validation02/28/2024 4:14:51 PM
Update time02/28/2024 4:14:51 PM
Status update02/28/2024 4:14:51 PM
Last indexation05/04/2024 2:17:09 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack